Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15

The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol (1996) 5.41

Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J (1996) 5.14

The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J (1996) 5.09

Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res (1996) 4.75

Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol (1995) 4.04

Muscleblind proteins regulate alternative splicing. EMBO J (2004) 4.01

The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol (2001) 3.68

Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science (2009) 3.62

Replication fork stalling at natural impediments. Microbiol Mol Biol Rev (2007) 3.47

Comparative genomics and molecular dynamics of DNA repeats in eukaryotes. Microbiol Mol Biol Rev (2008) 3.35

Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A (2006) 3.09

Equilibrium distributions of microsatellite repeat length resulting from a balance between slippage events and point mutations. Proc Natl Acad Sci U S A (1998) 3.02

Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet (1992) 2.85

Receptor-like genes in the major resistance locus of lettuce are subject to divergent selection. Plant Cell (1998) 2.83

Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest (2007) 2.68

Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature (2012) 2.63

The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J Biol Chem (2008) 2.60

Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet (1993) 2.42

Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet (2010) 2.36

Trinucleotide repeats associated with human disease. Nucleic Acids Res (1997) 2.35

Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans (2009) 2.32

Fission yeast orb6, a ser/thr protein kinase related to mammalian rho kinase and myotonic dystrophy kinase, is required for maintenance of cell polarity and coordinates cell morphogenesis with the cell cycle. Proc Natl Acad Sci U S A (1998) 2.20

Simple tandem DNA repeats and human genetic disease. Proc Natl Acad Sci U S A (1995) 2.18

The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet (1992) 2.15

Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci U S A (1997) 2.10

Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization. Mol Cell Biol (1998) 2.08

Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum Mol Genet (2011) 2.05

Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1. Nat Struct Mol Biol (2008) 2.00

In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res (2001) 1.97

CTG repeat instability and size variation timing in DNA repair-deficient mice. EMBO J (2003) 1.96

The structural basis of myotonic dystrophy from the crystal structure of CUG repeats. Proc Natl Acad Sci U S A (2005) 1.96

Instability versus predictability: the molecular diagnosis of myotonic dystrophy. J Med Genet (1992) 1.94

Non-coding RNAs in the nervous system. J Physiol (2006) 1.87

Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet (1993) 1.86

Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet (2004) 1.85

Evidence for anticipation in schizophrenia. Am J Hum Genet (1994) 1.85

Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J Gen Physiol (2006) 1.83

Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet (2009) 1.80

Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J (2006) 1.80

Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet (1994) 1.71

Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci U S A (1997) 1.66

The tricornered gene, which is required for the integrity of epidermal cell extensions, encodes the Drosophila nuclear DBF2-related kinase. Genetics (2000) 1.65

Orientation dependence of trinucleotide CAG repeat instability in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.63

Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet (1995) 1.62

Fragile X gene instability: anchoring AGGs and linked microsatellites. Am J Hum Genet (1995) 1.61

Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc Natl Acad Sci U S A (1995) 1.60

Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet (2003) 1.59

A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet (2006) 1.55

Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J Med Genet (1994) 1.54

Controlling the specificity of modularly assembled small molecules for RNA via ligand module spacing: targeting the RNAs that cause myotonic muscular dystrophy. J Am Chem Soc (2009) 1.54

Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. Am J Hum Genet (1997) 1.53

Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes. Am J Hum Genet (1993) 1.50

How is the Human Genome Project doing, and what have we learned so far? Proc Natl Acad Sci U S A (1995) 1.50

Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet (1992) 1.49

Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy. Dev Med Child Neurol (2015) 1.47

Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet (1994) 1.46

Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc Natl Acad Sci U S A (1997) 1.45

The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol (2013) 1.45

Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching. J Am Chem Soc (2012) 1.44

A common trinucleotide repeat expansion within the transcription factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystrophy. PLoS One (2012) 1.44

Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J (1998) 1.43

Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations. J Med Genet (1992) 1.41

RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Proc Natl Acad Sci U S A (2012) 1.40

High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. J Neurol (2008) 1.37

Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet (2011) 1.37

The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain (2011) 1.36

CUGBP1 and MBNL1 preferentially bind to 3' UTRs and facilitate mRNA decay. Sci Rep (2012) 1.35

MSH2-dependent germinal CTG repeat expansions are produced continuously in spermatogonia from DM1 transgenic mice. Mol Cell Biol (2004) 1.30

Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res (2011) 1.29

Codon reiteration and the evolution of proteins. Proc Natl Acad Sci U S A (1994) 1.29

Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet (1993) 1.28

Structural insights into CUG repeats containing the 'stretched U-U wobble': implications for myotonic dystrophy. Nucleic Acids Res (2009) 1.28

The unstable repeats--three evolving faces of neurological disease. Neuron (2013) 1.26

Rodent models of TDP-43: recent advances. Brain Res (2012) 1.24

Myotonic dystrophy: the role of RNA CUG triplet repeats. Am J Hum Genet (1999) 1.24

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. Br J Cancer (1999) 1.23

MSH2 ATPase domain mutation affects CTG*CAG repeat instability in transgenic mice. PLoS Genet (2009) 1.22

The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects. Arch Dis Child (1993) 1.22

Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol (2013) 1.22

DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest (1999) 1.20

Repeat-associated non-ATG (RAN) translation in neurological disease. Hum Mol Genet (2013) 1.20

The GAA triplet-repeat is unstable in the context of the human FXN locus and displays age-dependent expansions in cerebellum and DRG in a transgenic mouse model. Hum Genet (2006) 1.20

Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range. J Med Genet (1993) 1.20

Segregation distortion of the CTG repeats at the myotonic dystrophy locus. Am J Hum Genet (1996) 1.19

Bidirectional transcription stimulates expansion and contraction of expanded (CTG)*(CAG) repeats. Hum Mol Genet (2010) 1.19

Length variation of CAG/CAA trinucleotide repeats in natural populations of Drosophila melanogaster and its relation to the recombination rate. Genetics (1996) 1.18

Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle. Am J Pathol (2008) 1.17

Therapeutic advances in muscular dystrophy. Ann Neurol (2013) 1.17

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet (2012) 1.17

Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. Prog Mol Subcell Biol (2006) 1.16

Simple sequence repeats in zebra finch (Taeniopygia guttata) expressed sequence tags: a new resource for evolutionary genetic studies of passerines. BMC Genomics (2007) 1.16

Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup. J Med Genet (1997) 1.15

Conserved serine/threonine kinase encoded by CBK1 regulates expression of several hypha-associated transcripts and genes encoding cell wall proteins in Candida albicans. J Bacteriol (2002) 1.15

Gametic but not somatic instability of CAG repeat length in Huntington's disease. J Med Genet (1993) 1.15

Structure and dynamics of the DNA hairpins formed by tandemly repeated CTG triplets associated with myotonic dystrophy. Nucleic Acids Res (1996) 1.14

Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. J Transl Med (2010) 1.13

MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res (2009) 1.13

Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract. Am J Hum Genet (2003) 1.13

Drosophila models of neurodegenerative disease. NeuroRx (2005) 1.12

Initial sequencing and analysis of the human genome. Nature (2001) 212.86

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13

Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature (1992) 8.85

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell (1990) 8.30

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature (1997) 5.55

The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet (1997) 5.39

FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science (1998) 5.29

Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet (1997) 4.92

E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev (1998) 4.60

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet (1996) 4.59

INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev (1999) 4.13

Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A (1997) 3.18

The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet (1996) 3.05

An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell (1990) 3.02

On some genetic aspects of phage lambda resistance in E. coli K12. Genetics (1972) 2.99

Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet (1992) 2.85

Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci U S A (1991) 2.83

Genetic risks for children of women with myotonic dystrophy. Am J Hum Genet (1991) 2.65

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity (1994) 2.59

Automatic 3-D segmentation of internal structures of the head in MR images using a combination of similarity and free-form transformations: Part I, Methodology and validation on normal subjects. IEEE Trans Med Imaging (1999) 2.57

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A (1998) 2.46

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 2.38

Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene (2007) 2.34

PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev (2000) 2.33

Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nat Genet (1994) 2.33

Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat Genet (1999) 2.28

Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology (1997) 2.24

Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev (1991) 2.20

Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci U S A (2000) 2.19

Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis. Genomics (2000) 2.14

Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08

Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci U S A (1990) 2.06

Use of denaturing gradient gel electrophoresis to study conformational transitions in nucleic acids. Methods Enzymol (1992) 1.97

Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci U S A (1999) 1.97

p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res (1994) 1.95

Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A (1990) 1.87

Mitochondrial targeting of human DNA glycosylases for repair of oxidative DNA damage. Nucleic Acids Res (1998) 1.83

Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol (2005) 1.73

The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas. Br J Cancer (2009) 1.70

Ordering three DNA polymorphisms on human chromosome 3 by sperm typing. Genomics (1991) 1.69

Lipid composition of Saccharomyces cerevisiae as influenced by growth temperature. Biochim Biophys Acta (1972) 1.66

Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob Agents Chemother (2008) 1.65

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62

Determining the cost of genital warts: a study from Ireland. Sex Transm Infect (2008) 1.60

Galactokinase mutants of Chinese hamster somatic cells resistant to 2-deoxygalactose. Genetics (1976) 1.59

Transcranial magnetic stimulation for the treatment of seizures: a controlled study. Neurology (2002) 1.59

Independent regulation of transcription of the two strands of the c-myc gene. Mol Cell Biol (1987) 1.58

The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet (1992) 1.56

Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab (2001) 1.53

p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins. EMBO J (1996) 1.52

Protein synthesis requirements for nuclear division, cytokinesis, and cell separation in Saccharomyces cerevisiae. Mol Cell Biol (1991) 1.50

Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res (2001) 1.50

A scheme for automatically building three-dimensional morphometric anatomical atlases: application to a skull atlas. Med Image Anal (1998) 1.46

Noninvasive imaging by optical coherence tomography to monitor retinal degeneration in the mouse. Invest Ophthalmol Vis Sci (2001) 1.44

Iodine supplementation: comparison of oral or intramuscular iodized oil with oral potassium iodide. A controlled trial in Zaire. Int J Epidemiol (1988) 1.44

Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene (2006) 1.43

Ordered restriction endonuclease maps of yeast artificial chromosomes created by optical mapping on surfaces. Proc Natl Acad Sci U S A (1995) 1.42

Measuring the results of faith. Hosp Health Netw (1996) 1.41

Factoring in the financials. Court gives nod to economic credentialing ... Rosenblum v. Tallahassee Memorial Regional Medical Center. Hospitals (1993) 1.40

Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences. Mol Cell Biol (1987) 1.39

Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence. Ann Oncol (2010) 1.39

Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol (2006) 1.38

Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev (2001) 1.35

Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med (1995) 1.35

Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet (1998) 1.33

Distinct repair activities of human 7,8-dihydro-8-oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine. J Biol Chem (2000) 1.33

Hepatocellular carcinoma in Txnip-deficient mice. Oncogene (2006) 1.31

Saccharomyces cerevisiae fungemia: case report and review of the literature. Diagn Microbiol Infect Dis (1987) 1.30

Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Ann Trop Med Parasitol (2003) 1.29

Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. Cancer Res (1994) 1.29

Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene (2007) 1.28

Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J Leukoc Biol (1991) 1.24

Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections. J Clin Microbiol (1999) 1.20

Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR. J Clin Microbiol (1995) 1.18

Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab. Rheumatology (Oxford) (2008) 1.17

Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Oncogene (2010) 1.16

Osteoid osteoma of the elbow. A review of six cases. Skeletal Radiol (1990) 1.16

Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells. Br J Cancer (2009) 1.15

Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol (2009) 1.14

Eμ/miR-125b transgenic mice develop lethal B-cell malignancies. Leukemia (2011) 1.14

Cortical localization of reading in normal children: an fMRI language study. Neurology (2001) 1.14

Sperm typing allows accurate measurement of the recombination fraction between D3S2 and D3S3 on the short arm of human chromosome 3. Genomics (1992) 1.13

A multivariate analysis of evoked responses in EEG and MEG data. Neuroimage (1996) 1.13

Efficient high-resolution genetic mapping of mouse interspersed repetitive sequence PCR products, toward integrated genetic and physical mapping of the mouse genome. Proc Natl Acad Sci U S A (1995) 1.12

A recombination event that redefines the Huntington disease region. Am J Hum Genet (1992) 1.11

Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. Drug Metab Dispos (1996) 1.11

Detection of single base mismatches of thymine and cytosine residues by potassium permanganate and hydroxylamine in the presence of tetralkylammonium salts. Nucleic Acids Res (1990) 1.10

Tissue protein synthesis rates in critically ill patients. Crit Care Med (1998) 1.10

MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet (1994) 1.09